SCD34 LIGAND HUMAN, ;, recombinant, exprimé dans les cellules CHO, > = 95% (SDS - PAGE ), >=95%( HPLC)

Code: srp3282-20ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

CD34 is a highly glycosylated type I membrane protein that is selectively expressed on hematopoietic stem cells and vascular endothelium. Recombinant ...


en savoir plus

Votre prix
£300.00 20UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

CD34 is a highly glycosylated type I membrane protein that is selectively expressed on hematopoietic stem cells and vascular endothelium. Recombinant human sCD34 is a 258 amino acid polypeptide containing only the extracellular domain of the full length CD34 protein.

General description

CD34 has been widely used as a molecular marker for the identification, isolation, and manipulation of hemopoietic stem cells and progenitors. CD34 can function as a regulator of hemopoietic cell adhesion by mediating the attachment of stem cells to bone marrow stromal cells or other bone marrow components. The full length human CD34 is a 385 amino acid protein, consisting of a 31 amino acid signal sequence, a 74 amino acid cytoplasmic domain, a 21 amino acid transmembrane domain and a 259 amino acid extracellular domain.

Physical form

Lyophilized from 10 mM Sodium Phosphate, pH 7.5.

Reconstitution

Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/mL. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.

assay≥95% (HPLC), ≥95% (SDS-PAGE)
biological sourcehuman
colorwhite
formlyophilized
Gene Informationhuman ... CD34(947)
impurities﹤0.1 EU/µg endotoxin, tested
mol wt70.0-80.0 kDa
packagingpkg of 20 µg
recombinantexpressed in CHO cells
shipped inwet ice
storage temp.−20°C
UniProt accession no.P28906
Ce produit répond aux critères suivants: